Effects of bromhexine metabolite VIII (NA 872) in an animal model of the respiratory distress syndrome. 1980

R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D001775 Blood Circulation The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D001964 Bromhexine A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744) Aparsonin,Bisolvon,Bromhexin,Bromhexin BC,Bromhexin Berlin-Chemie,Bromhexin-ratiopharm,Bromhexine Hydrochloride,Bromhexine Monohydrochloride,Brotussol,Darolan,Dur-Elix,Famel Bromhexine,Flegamin,Flubron,Hustentabs-ratiopharm,Mucohexine,NA-274,Quentan,Tesacof,bromhexin von ct,BC, Bromhexin,Bromhexin Berlin Chemie,Bromhexin BerlinChemie,Bromhexin ratiopharm,Bromhexine, Famel,Bromhexinratiopharm,Dur Elix,DurElix,Hustentabs ratiopharm,Hustentabsratiopharm,Hydrochloride, Bromhexine,Monohydrochloride, Bromhexine,NA 274,NA274,ct, bromhexin von,von ct, bromhexin
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000551 Ambroxol A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride. Bromhexine Metabolite VIII,4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol,AMBROPP,Abrohexal,Ambril,Ambro-Puren,Ambrobeta,Ambrofur,Ambrohexal,Ambrolitic,Ambrolös,Ambroten,Ambroxin,Ambroxocompren,Bisolvon AM,Bronchopront,Bronchowern,Broxol,Contac Husten-Trunk,Dinobroxol,Duramucal,Ebromin,Expeflen,Expit,Farmabroxol,Flavamed,Frenopect,Gelopol,Larylin Husten-Löser,Lasolvan,Mibrox,Motosol,Muco-Fips,Mucosolvan,Mucotablin,NA-872,Pect Hustenlöser,Pulmonal S,Pädiamuc,Ringelheimer Pulmonal,Sekretovit,Surbronc,Therapin Hustenlöser,stas-Hustenlöser,AM, Bisolvon,Ambro Puren,AmbroPuren,Contac Husten Trunk,Contac HustenTrunk,Hustenlöser, Pect,Hustenlöser, Therapin,Larylin Husten Löser,Larylin HustenLöser,Metabolite VIII, Bromhexine,Muco Fips,MucoFips,NA 872,NA872,Pulmonal, Ringelheimer,stas Hustenlöser,stasHustenlöser
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
January 2008, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
April 1978, European journal of obstetrics, gynecology, and reproductive biology,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
January 1979, Respiration; international review of thoracic diseases,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
December 2014, Intensive care medicine experimental,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
November 1975, Archiv fur Gynakologie,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
June 1994, Pediatric research,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
January 1983, Lung,
R Dauberschmidt, and W Kuckelt, and V Bender, and U Hieronymi, and H Mrochen, and K Winsel, and J Zinsmeyer, and M Meyer
July 1977, Archiv fur Gynakologie,
Copied contents to your clipboard!